Random aneuploidy in CML patients at diagnosis and under imatinib treatment

Cancer Genetics and Cytogenetics

Volumn 168, Issue 2, 2006, Pages 120-123

  Amiel, A ^a,b   Yukla, M ^a   Gaber, E ^a   Leopold, L ^a,c   Josef, G ^a   Fejgin, M ^a,c   Lishner, M ^a,c  

^a MEIR MEDICAL CENTER   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB; INTERFERON;

ADULT; AGED; ANEUPLOIDY; ARTICLE; BONE MARROW; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CELL NUCLEUS; CHROMOSOMAL INSTABILITY; CHROMOSOME 18; CHROMOSOME 9; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TRIPLOIDY;

ADULT; AGED; ANEUPLOIDY; ANTINEOPLASTIC AGENTS; FEMALE; GENOMIC INSTABILITY; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; PIPERAZINES; PYRIMIDINES; TUMOR CELLS, CULTURED;

EID: 33745726051     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2006.02.002     Document Type: Article

References (31)

1. Nowell P., and Hungerford D. A minute chromosome in human chronic granulocytic leukemia. Science 132 (1960) 1497-1500
2. Rowley J.D. A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and giemsa staining. Nature 243 (1973) 290-293
3. Vardiman J.W., Pierre R., and Thiele J. Chronic myeloproliferative diseases. In: Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). Pathology and genetics of tumors of haematopoietic and lymphoid tissues (2001), IARC Press, Lyon 15-59
4. Daley G.Q., Van Etten R.A., and Baltimore D. Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science 247 (1990) 824-830
5. Lugo T.G., Pendergast A.M., Muller A.J., and Witte O.N. Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science 247 (1990) 1079-1082
6. Deininger M., Buchdunger E., and Druker B.J. The development of imatinib as a therapeutic agent for chronic myeloid leukemia. Blood 105 (2005) 2640-2653
7. Li R., Yerganian G., Duesberg P., Kraemer A., Willer A., Rausch C., and Hehlmann R. Aneuploidy correlated 100% with chemical transformation of Chinese hamster cells. Proc Natl Acad Sci USA 94 (1997) 14506-14511
8. Rasnick D., and Duesberg P. How aneuploidy affects metabolic control and causes cancer. Biochem J 340 (1999) 621-630
9. Li R., Sonik A., Stindl R., Rasnick D., and Duesberg P. Aneuploidy versus gene mutation hypothesis of cancer: recent study claims mutation, but is found to support aneuploidy. Proc Natl Acad Sci USA 97 (2000) 3236-3241
10. Duesberg P., and Li R. Multistep carcinogenesis: a chain reaction of aneuploidizations. Cell Cycle 2 (2003) 202-210
11. Duesberg P., and Rasnick D. Aneuploidy, the somatic mutation that makes cancer a species of its own. Cell Motil Cytoskel 47 (2000) 81-107
12. Duesberg P., Fabarius A., and Hehlmann R. Aneuploidy, the primary cause of the multilateral genomic instability of neoplastic and preneoplastic cells. IUBMB Life 56 (2004) 65-81
13. Lewin B. Genes VI (1997), Oxford University Press, Oxford
14. Duesberg P., Li R., Rasnick D., Rausch C., Willer A., Kraemer A., Yerganian G., and Hehlmann R. Aneuploidy precedes and segregates with chemical carcinogenesis. Cancer Genet Cytogenet 119 (2000) 83-93
15. Fabarius A., Willer A., Yerganian G., Hehlmann R., and Duesberg P. Specific aneusomies in Chinese hamster cells at different stages of neoplastic transformation, initiated by nitrosomethylurea. Proc Natl Acad Sci USA 99 (2002) 6778-6783
16. Terre C., Eclache V., Rousselot P., Imbert M., Charrin C., and Gervais C. France intergroupe pour la leucemie Myeloide Chronique. Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia. Leukemia 18 (2004) 1340-1346
17. Andersen M.K., Pedersen-Biergaard J., Kjeldsen L., Dufva I.H., and Brondum-Nielsen K. Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequent characterized by trisomy 8. Leukemia 16 (2002) 1390-1395
18. Braziel R.M., Launder T.M., Druker B.J., Olson S.B., Magenis R.E., and Mauro M.J. Hematopathologic and cytogenetic findings in imatinib mesylate-treated chronic myelogenous leukemia patients: 14 month's experience. Blood 100 (2002) 435-441
19. Bacher U., Hochhaus A., Berger U., Hiddemann W., Hehlmann R., Haferlach T., and Schoch C. Clonal aberrations in Philadelphia chromosome negative hematopoiesis in patients with chronic myeloid leukemia treated with imatinib or interferon alpha. Leukemia 19 (2005) 460-463
20. Schoch C., Haferlach T., Kern W., Schnittger S., Berger U., Hehlmann R., Hiddemann W., and Hochhaus A. Occurrence of additional chromosome aberrations in chronic myeloid leukemia patients treated with imatinib mesylate. Leukemia 17 (2003) 461-463
21. O'Dwyer M.E., Gatter K.M., Loriaux M., Druker B.J., Olson S.B., and Magenis R.E. Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate. Leukemia 17 (2005) 481-487
22. Lahaye T., Riehm B., Berger U., Paschka P., Muller M.C., Kreil S., Merx K., Schwindel U., Schoch C., Hehlmann R., and Hochhaus A. Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a singe center. Cancer 103 (2005) 1659-1669
23. Giehl M., Fabarius A., Frank O., Hochhaus A., Hafner M., Hehlmann R., and Seifarth W. Centrosome aberrations in chronic myeloid leukemia correlate with stage of disease and chromosomal instability. Leukemia 19 (2005) 1192-1197
24. Fabarius A., Giehl M., Frank O., Duesberg P., Hochhaus A., Hehlmann R., and Seifarth W. Induction of centrosome and chromosome aberrations by imatinib in vitro. Leukemia 9 (2005) 1573-1578
25. Amiel A., Drori G., Weinstein G., and Fejgin M.D. Molecular cytogenetic parameters in fibroblasts of ataxia telangiectasia carrier. Cancer Genet Cytogenet 153 (2004) 102-107
26. Amiel A., Gronich N., Yukla M., Suliman S., Josef G., and Gaber E. Random aneuploidy in neoplastic and pre-neoplastic diseases. Multiple myeloma and monoclonal gammopathy. Cancer Genet Cytogenet 162 (2005) 78-81
27. Amiel A., Goldzak G., Gaber E., Yosef G., Fejgin M.D., Yukla M., and Lishner M. Random aneuploidy and telomere capture in chronic lymphocytic leukemia and chronic myeloid leukemia patients. Cancer Genet Cytogenet 163 (2005) 12-16
28. Bumm T., Muller C., Al-Ali H.K., Krohn K., Shepherd P., Schmidt E., Leiblein S., Franke C., Hennig E., Friedrich T., Krahl R., Niederwieser D., and Deininger M.W. Emergence of clonal cytogenetic abnormalities in Ph- cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority. Blood 101 (2003) 1941-1949
29. Calabretta B., and Perrotti D. The biology of CML blast crisis. Blood 103 (2004) 4010-4022
30. Izumi T., Imagawa S., Hatake K., Miura Y., Ariyama T., Inazawa J., and Abe T. Philadelphia chromosome-negative cells with trisomy 8 after busulfan and interferon treatment of Ph1-positive CML. Int J Hematol 64 (1996) 73-77
31. Ohtsuka E., Kikuchi H., Abe Y., Moriyama K., Ohno E., Hirota K., Tezono K., and Nasu M. Acute myeloblastic leukaemia without Philadelphia chromosome developing after interferon therapy for chronic myelocytic leukemia with Philadelphia chromosome. Br J Haematol 90 (1995) 951-953